Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
210
-
Total 13F shares, excl. options
-
88.5M
-
Shares change
-
-122K
-
Total reported value, excl. options
-
$640M
-
Value change
-
+$7.17M
-
Put/Call ratio
-
0.22
-
Number of buys
-
108
-
Number of sells
-
-107
-
Price
-
$7.23
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q3 2025
253 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q3 2025.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 210 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 88.5M shares
of 93.1M outstanding shares and own 95.07% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (14.9M shares), VANGUARD GROUP INC (7.88M shares), STATE STREET CORP (4.98M shares), MILLENNIUM MANAGEMENT LLC (4.75M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (4.59M shares), D. E. Shaw & Co., Inc. (4.56M shares), MORGAN STANLEY (3.62M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (2.44M shares), GEODE CAPITAL MANAGEMENT, LLC (2.23M shares), and GOLDMAN SACHS GROUP INC (2.15M shares).
This table shows the top 210 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.